Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A patient with probable rare blood Group B(A) phenotype.
Chandra A, Bhasker PMB, Jain R, Kumar R, Srivastava S. Chandra A, et al. Among authors: srivastava s. Asian J Transfus Sci. 2024 Jul-Dec;18(2):320-322. doi: 10.4103/ajts.ajts_166_21. Epub 2022 Sep 28. Asian J Transfus Sci. 2024. PMID: 39822701 Free PMC article.
Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.
Vogensen VB, Singh S, Allende CJ, Engelthaler DM, Boorgula GD, Thomas TA, Sturkenboom MGG, Akkerman OW, Gumbo T, Srivastava S. Vogensen VB, et al. Among authors: srivastava s. Antimicrob Agents Chemother. 2025 Jan 16:e0108424. doi: 10.1128/aac.01084-24. Online ahead of print. Antimicrob Agents Chemother. 2025. PMID: 39817762
Docetaxel and Niclosamide-loaded Nanofiber systems for Improved Chemo-therapeutic Activity and Resistance Reversal in Prostate Cancer.
Shah S, Famta P, Vambhurkar G, Kumar R, Pandey G, Singh G, Wagh S, Kanaujiya S, Arya DK, Sharma A, Shinde A, Bhanu Prasad S, Chandankar S, Shinde S, Sharma A, Rajinikanth PS, Khatri DK, Asthana A, Srivastava S. Shah S, et al. Among authors: srivastava s. Drug Dev Ind Pharm. 2025 Jan 15:1-14. doi: 10.1080/03639045.2025.2453533. Online ahead of print. Drug Dev Ind Pharm. 2025. PMID: 39815752
Climate change impacts and pandemics.
Srivastava S, Mehta R, Mohanty A, Satapathy P, Sah R, Apostoloopoulos V. Srivastava S, et al. New Microbes New Infect. 2024 Dec 13;63:101556. doi: 10.1016/j.nmni.2024.101556. eCollection 2025 Feb. New Microbes New Infect. 2024. PMID: 39811748 Free PMC article. No abstract available.
Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.
Truong DT, Trachtenberg FL, Hu C, Pearson GD, Friedman K, Sabati AA, Dionne A, Oster ME, Anderson BR, Block J, Bradford TT, Campbell MJ, D'Addese L, Dummer KB, Elias MD, Forsha D, Garuba OD, Hasbani K, Hayes K, Hebson C, Jone PN, Krishnan A, Lang S, McCrindle BW, McHugh KE, Mitchell EC, Morrison T, Muniz JC, Payne RM, Portman MA, Russell MW, Sanil Y, Shakti D, Sharma K, Shea JR, Sykes M, Shekerdemian LS, Szmuszkovicz J, Thacker D, Newburger JW; MUSIC Study Investigators. Truong DT, et al. JAMA Pediatr. 2025 Jan 13. doi: 10.1001/jamapediatrics.2024.5466. Online ahead of print. JAMA Pediatr. 2025. PMID: 39804656
A Phase III, Double-Blind, Randomized, Multicenter, Clinical Trial to Evaluate the Efficacy and Safety of a Fixed-Dose Combination of Metformin Hydrochloride and Myo-Inositol Compared to Metformin in Patients With Polycystic Ovary Syndrome.
Kriplani A, Tank P, Singh P, Maini N, Kaitala S, Kantha G L, Paul J, Shah S, Bhatara U, Sinha A, Singh T, Srivastava S, Malvi A. Kriplani A, et al. Among authors: srivastava s. Cureus. 2024 Dec 12;16(12):e75616. doi: 10.7759/cureus.75616. eCollection 2024 Dec. Cureus. 2024. PMID: 39803009 Free PMC article.
6,487 results